[HTML][HTML] MicroRNAs and the cell cycle

MJ Bueno, M Malumbres - Biochimica et Biophysica Acta (BBA)-Molecular …, 2011 - Elsevier
The control of cell proliferation by microRNAs (miRNAs) is well established and the
alteration of these small, non-coding RNAs may contribute to tumor development by …

The oncogenic role of miR-155 in breast cancer

S Mattiske, RJ Suetani, PM Neilsen, DF Callen - … epidemiology, biomarkers & …, 2012 - AACR
Abstract miR-155 is an oncogenic miRNA with well described roles in leukemia. However,
additional roles of miR-155 in breast cancer progression have recently been described. A …

Pathogenesis of pituitary tumors

S Melmed - Nature Reviews Endocrinology, 2011 - nature.com
Pituitary adenomas may hypersecrete hormones (including prolactin, growth hormone and
adrenocorticotropic hormone, and rarely follicle-stimulating hormone, luteinizing hormone or …

Oncogenic microRNAs: key players in malignant transformation

T Frixa, S Donzelli, G Blandino - Cancers, 2015 - mdpi.com
MicroRNAs (miRNAs) represent a class of non-coding RNAs that exert pivotal roles in the
regulation of gene expression at the post-transcriptional level. MiRNAs are involved in many …

The role of microRNAs in biological processes

KU Tüfekci, RLJ Meuwissen, Ş Genç - miRNomics: microRNA biology and …, 2014 - Springer
MicroRNAs (miRNAs) are tiny regulators of gene expression on the posttranscriptional level.
Since the discovery of the first miRNA 20 years ago, thousands of them have been …

[HTML][HTML] microRNA-155 regulates cell proliferation and invasion by targeting FOXO3a in glioma

N Ling, J Gu, Z Lei, M Li, J Zhao… - Oncology …, 2013 - spandidos-publications.com
Abstract microRNAs (miRNAs) are short noncoding RNAs, which modulate the expression of
numerous genes by targeting mRNAs. Numerous abnormal miRNA expression patterns are …

Cross talk between cancer and mesenchymal stem cells through extracellular vesicles carrying nucleic acids

T Lopatina, C Gai, MC Deregibus, S Kholia… - Frontiers in …, 2016 - frontiersin.org
Extracellular vesicles (EVs) are considered to be a novel complex mechanism of cell
communication within the tumor microenvironment. EVs may act as vehicles for transcription …

Synthetic and medicinal chemistry approaches toward WEE1 kinase inhibitors and its degraders

VJ Alli, P Yadav, V Suresh, SS Jadav - ACS omega, 2023 - ACS Publications
WEE1 is a checkpoint kinase critical for mitotic events, especially in cell maturation and DNA
repair. Most cancer cells' progression and survival are linked with elevated levels of WEE1 …

MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas

H Butz, I Likó, S Czirják, P Igaz, M Korbonits, K Rácz… - Pituitary, 2011 - Springer
Abstract MicroRNAs (miRs) are small, 16–29 nucleotide long, non-coding RNA molecules
which regulate the stability or translational efficiency of targeted mRNAs via RNA …

Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies

G Raverot, E Jouanneau… - European journal of …, 2014 - academic.oup.com
Pituitary tumours, the most frequent intracranial tumour, are historically considered benign.
However, various pieces of clinical evidence and recent advances in pathological and …